What is the current valuation of the US pharmaceutical sterility-testing market?

The market valuation was $141.54 Million in 2024. Read More

What is the projected market size for the US pharmaceutical sterility-testing market by 2035?

The projected valuation for 2035 is $249.85 Million. Read More

What is the expected CAGR for the US pharmaceutical sterility-testing market during the forecast period 2025 - 2035?

The expected CAGR is 5.3% during the forecast period. Read More

Which companies are considered key players in the US pharmaceutical sterility-testing market?

Key players include Merck KGaA, Thermo Fisher Scientific Inc., and Charles River Laboratories International Inc. Read More

What are the main segments of the US pharmaceutical sterility-testing market?

Main segments include Sample, Product Type, Type, Test Type, and End User. Read More

What was the valuation of the sterile drugs segment in 2024?

The valuation of the sterile drugs segment was $45.0 Million in 2024. Read More

How much is the kits and reagents segment projected to be worth by 2035?

The kits and reagents segment is projected to reach $120.0 Million by 2035. Read More

What is the valuation range for bioburden testing in the US pharmaceutical sterility-testing market?

The valuation range for bioburden testing is between $40.0 Million and $70.0 Million. Read More

Which end user segment had the highest valuation in 2024?

The pharmaceutical companies segment had the highest valuation at $71.54 Million in 2024. Read More

What is the projected valuation for the outsourcing type segment by 2035?

The projected valuation for the outsourcing type segment is approximately $124.85 Million by 2035. Read More

US Pharmaceutical Sterility Testing Market

US Pharmaceutical Sterility Testing Market Research Report: Size, Share, Trend Analysis By Applications (Sterile Drugs, Medical Devices, Biologics), By Product Type (Instruments, Kits & Reagents, Services), By Types (In-house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing) and By End Users (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.3%

2024 Market Size

$ 141.54 Million

2035 Market Size

$ 249.85 Million

Pharmaceutical ● Updated April 2026 Report ID: MRFR/Pharma/18148-HCR | Pages: 100 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Sample (USD Million)
  1. 4.1.1 Sterile Drugs
  2. 4.1.2 Medical Devices
  3. 4.1.3 Biologics
2. 4.2 Industrial Automation & Equipment, BY Product Type (USD Million)
  1. 4.2.1 Instruments
  2. 4.2.2 Kits & Reagents
  3. 4.2.3 Services
3. 4.3 Industrial Automation & Equipment, BY Type (USD Million)
  1. 4.3.1 In-house
  2. 4.3.2 Outsourcing
4. 4.4 Industrial Automation & Equipment, BY Test Type (USD Million)
  1. 4.4.1 Sterility Testing
  2. 4.4.2 Bioburden Testing
  3. 4.4.3 Bacterial Endotoxin Testing
5. 4.5 Industrial Automation & Equipment, BY End User (USD Million)
  1. 4.5.1 Compounding Pharmacies
  2. 4.5.2 Medical Devices Companies
  3. 4.5.3 Pharmaceutical Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Merck KGaA (DE)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific Inc. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Charles River Laboratories International Inc. (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Becton Dickinson and Company (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Eppendorf AG (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 BioMerieux SA (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 MilliporeSigma (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sartorius AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY SAMPLE
3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
4. 6.4 US MARKET ANALYSIS BY TYPE
5. 6.5 US MARKET ANALYSIS BY TEST TYPE
6. 6.6 US MARKET ANALYSIS BY END USER
7. 6.7 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SAMPLE, 2024 (% SHARE)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SAMPLE, 2024 TO 2035 (USD Million)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PRODUCT TYPE, 2024 (% SHARE)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TEST TYPE, 2024 (% SHARE)
20. 6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TEST TYPE, 2024 TO 2035 (USD Million)
21. 6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 (% SHARE)
22. 6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SAMPLE, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY TEST TYPE, 2025-2035 (USD Million)
  5. 7.2.5 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Sterility Testing Market Segmentation

US Pharmaceutical Sterility Testing Market By Sample (USD Million, 2025-2035)

Sterile Drugs
Medical Devices
Biologics

US Pharmaceutical Sterility Testing Market By Product Type (USD Million, 2025-2035)

Instruments
Kits & Reagents
Services

US Pharmaceutical Sterility Testing Market By Type (USD Million, 2025-2035)

In-house
Outsourcing

US Pharmaceutical Sterility Testing Market By Test Type (USD Million, 2025-2035)

Sterility Testing
Bioburden Testing
Bacterial Endotoxin Testing

US Pharmaceutical Sterility Testing Market By End User (USD Million, 2025-2035)

Compounding Pharmacies
Medical Devices Companies
US Pharmaceutical Sterility Testing Market Companies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”